These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10673128)

  • 1. Topical rivastigmine, a selective acetylcholinesterase inhibitor, lowers intraocular pressure in rabbits.
    Goldblum D; Garweg JG; Böhnke M
    J Ocul Pharmacol Ther; 2000 Feb; 16(1):29-35. PubMed ID: 10673128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit.
    Giacobini E; Spiegel R; Enz A; Veroff AE; Cutler NR
    J Neural Transm (Vienna); 2002 Jul; 109(7-8):1053-65. PubMed ID: 12111443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of the H-1152P, a potent Rho-associated coiled coil-formed protein kinase inhibitor, in rabbit normal and ocular hypertensive eyes.
    Nishio M; Fukunaga T; Sugimoto M; Ikesugi K; Sumi K; Hidaka H; Uji Y
    Curr Eye Res; 2009 Apr; 34(4):282-6. PubMed ID: 19373576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical application of a cyclic GMP analog lowers IOP in normal and ocular hypertensive rabbits.
    Stein PJ; Clack JW
    Invest Ophthalmol Vis Sci; 1994 May; 35(6):2765-8. PubMed ID: 8188470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical SDZ GLC-756, a novel dopamine D-1 antagonist and D-2 agonist, lowers intraocular pressure in conscious rabbits.
    Prünte C; Nuttli I; Markstein R
    Jpn J Ophthalmol; 1996; 40(2):167-73. PubMed ID: 8876383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months.
    Darreh-Shori T; Almkvist O; Guan ZZ; Garlind A; Strandberg B; Svensson AL; Soreq H; Hellström-Lindahl E; Nordberg A
    Neurology; 2002 Aug; 59(4):563-72. PubMed ID: 12196650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemin, an inducer of heme oxygenase-1, lowers intraocular pressure in rabbits.
    Privitera MG; Potenza M; Bucolo C; Leggio GM; Drago F
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):232-9. PubMed ID: 17593006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMA0076, a novel, locally acting Rho kinase inhibitor, potently lowers intraocular pressure in New Zealand white rabbits with minimal hyperemia.
    Van de Velde S; Van Bergen T; Sijnave D; Hollanders K; Castermans K; Defert O; Leysen D; Vandewalle E; Moons L; Stalmans I
    Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):1006-16. PubMed ID: 24474276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical 8-bromo-cyclic GMP lowers intraocular pressure in rabbits.
    Becker B
    Invest Ophthalmol Vis Sci; 1990 Aug; 31(8):1647-9. PubMed ID: 2167302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of topical diltiazem on the intraocular pressure in betamethasone-induced ocular hypertensive rabbits.
    Melena J; Santafé J; Segarra J
    J Pharmacol Exp Ther; 1998 Jan; 284(1):278-82. PubMed ID: 9435188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular hypotensive and aqueous outflow-enhancing effects of AL-3037A (sodium ferri ethylenediaminetetraacetate).
    Pang IH; Moll H; McLaughlin MA; Knepper PA; De Santis L; Epstein DL; Clark AF
    Exp Eye Res; 2001 Dec; 73(6):815-25. PubMed ID: 11846512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of outcome in retrieved dropout patients in a rivastigmine vs placebo, 26-week, Alzheimer disease trial.
    Farlow M; Potkin S; Koumaras B; Veach J; Mirski D
    Arch Neurol; 2003 Jun; 60(6):843-8. PubMed ID: 12810489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of pilocarpine in new ophthalmic formulations on intraocular pressure in rabbits with ocular hypertension].
    Xu Y; Chen Z; Song J
    Zhonghua Yan Ke Za Zhi; 2002 Dec; 38(12):721-4. PubMed ID: 12654220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-administration of memantine has no effect on the in vitro or ex vivo determined acetylcholinesterase inhibition of rivastigmine in the rat brain.
    Enz A; Gentsch C
    Neuropharmacology; 2004 Sep; 47(3):408-13. PubMed ID: 15275830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 5-HT(1A)Receptor agonist 8-OH-DPAT lowers intraocular pressure in normotensive NZW rabbits.
    Chidlow G; Nash MS; De Santis LM; Osborne NN
    Exp Eye Res; 1999 Dec; 69(6):587-93. PubMed ID: 10620387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular hypotensive activity of pirbuterol eye drops in rabbits.
    Bonomi L; Perfetti S; Bellucci R; De Franco I
    J Ocul Pharmacol; 1991; 7(3):191-4. PubMed ID: 1686050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro toxicity of rivastigmine and donepezil in cells of epithelial origin.
    Goldblum D; Gygax M; Böhnke M; Garweg JG
    Ophthalmic Res; 2002; 34(2):97-103. PubMed ID: 11914613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of intraocular pressure lowering by topical and systemic carbonic anhydrase inhibitors in the rabbit.
    Fanous MM; Challa P; Maren TH
    J Ocul Pharmacol Ther; 1999 Feb; 15(1):51-7. PubMed ID: 10048347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymmetry of 24-hour intraocular pressure reduction by topical ocular hypotensive medications in fellow eyes.
    Liu JH; Realini T; Weinreb RN
    Ophthalmology; 2011 Oct; 118(10):1995-2000. PubMed ID: 21676464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment Study.
    Brandt JD; Beiser JA; Gordon MO; Kass MA;
    Am J Ophthalmol; 2004 Nov; 138(5):717-22. PubMed ID: 15531304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.